Clinical study on glycemic excursion improvements with a DPP-4 inhibitor and a glinide in patients with type 2 diabetic mellitus - a comparative efficacy analysis using continuous glucose monitoring (CGM) -

Trial Profile

Clinical study on glycemic excursion improvements with a DPP-4 inhibitor and a glinide in patients with type 2 diabetic mellitus - a comparative efficacy analysis using continuous glucose monitoring (CGM) -

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2016

At a glance

  • Drugs Mitiglinide (Primary) ; Sitagliptin (Primary) ; Mitiglinide/voglibose
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 11 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 17 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top